StonvexLoading…
StonvexStonvexStonvexCore line items from BMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $48.19B | $48.30B | $45.01B | $46.16B |
Operating Income | $9.33B | $-8.38B | $8.44B | $7.71B |
Net Income | $7.05B | $-8.95B | $8.03B | $6.33B |
EPS (Diluted) | $3.46 | $-4.41 | $3.86 | $2.95 |
Total Assets | $90.04B | $92.60B | $95.16B | $96.82B |
Total Liabilities | $71.53B | $76.22B | $65.67B | $65.70B |
Cash & Equivalents | $10.21B | $10.35B | $11.46B | $9.12B |
Free Cash Flow OCF − CapEx | $12.85B | $13.94B | $12.65B | $11.95B |
Shares Outstanding | 2.04B | 2.03B | 2.08B | 2.15B |